Trial Profile
Phase I safety trial of ACE 537 in healthy subjects
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 13 Jun 2008
Price :
$35
*
At a glance
- Drugs ACE 527 (Primary)
- Indications Enterotoxigenic Escherichia coli infections
- Focus Adverse reactions
- 13 Jun 2008 New trial record.